Association between mitochondrial and nuclear DNA damages and cellular senescence in the patients with biliary atresia undergoing Kasai portoenterostomy and liver transplantation

Med Mol Morphol. 2022 Jun;55(2):131-145. doi: 10.1007/s00795-022-00314-z. Epub 2022 Mar 3.

Abstract

Biliary atresia (BA) is a cholestatic disease with extrahepatic bile duct obstruction that requires early surgical intervention and occasionally liver transplantation (LT). Accumulation of toxic bile acids induces oxidative stress that results in cell damage, such as cell senescence, mitochondrial dysfunction and others. However, details of their reciprocal association and clinical significance are unexplored. Therefore, we used immuno-localization of markers for cell senescence (p16 and p21), nuclear double-strand DNA damage (γH2AX), autophagy (p62), and mtDNA damage (mtDNA copy number) in patients with BA who underwent Kasai portoenterostomy (KP) and LT. We studied liver biopsy specimens from 54 patients with BA, 14 who underwent LT and 11 from the livers of neonates and infants obtained at autopsy. In hepatocytes, p21 expression was significantly increased in KP. In cholangiocytes, p16 expression was significantly increased in LT, and p21 expression was significantly increased in KP. p62 expression was significantly increased in the KP hepatocytes and LT cholangiocytes. Furthermore, mtDNA copy number significantly decreased in KP and LT compared with the control. Cell senescence and mitochondrial DNA damage progression were dependent on the BA clinical stages and could possibly serve as the markers of indication of LT.

Keywords: Biliary atresia; DNA damage; Kasai portoenterostomy; Liver; Mitochondrial damage; Senescence.

MeSH terms

  • Biliary Atresia* / genetics
  • Biliary Atresia* / metabolism
  • Biliary Atresia* / surgery
  • Biomarkers / metabolism
  • Cellular Senescence
  • DNA Damage
  • DNA, Mitochondrial / genetics
  • DNA, Mitochondrial / metabolism
  • Humans
  • Infant
  • Infant, Newborn
  • Liver / pathology
  • Liver Transplantation* / adverse effects
  • Liver Transplantation* / methods
  • Mitochondria / genetics
  • Mitochondria / pathology
  • Portoenterostomy, Hepatic

Substances

  • Biomarkers
  • DNA, Mitochondrial